MX2008001317A - Composiciones en forma de particulas que comprenden alginato y/o acido alginico. - Google Patents
Composiciones en forma de particulas que comprenden alginato y/o acido alginico.Info
- Publication number
- MX2008001317A MX2008001317A MX2008001317A MX2008001317A MX2008001317A MX 2008001317 A MX2008001317 A MX 2008001317A MX 2008001317 A MX2008001317 A MX 2008001317A MX 2008001317 A MX2008001317 A MX 2008001317A MX 2008001317 A MX2008001317 A MX 2008001317A
- Authority
- MX
- Mexico
- Prior art keywords
- alginate
- alginic acid
- particulate compositions
- particulate composition
- particulate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/009—Sachets, pouches characterised by the material or function of the envelope
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composicion en forma de particulas ingerible comprende: a. un alginato y/o acido alginico; b. un bicarbonato y/o carbonato; c. Un acido organico; y d. un aglomerante, que es un compuesto tal como un poliol de bajo peso molecular, el cual permite a la composicion en forma de particulas fluir aunque sustancialmente no libere particulas finas en el aire. Las composiciones en forma de particulas resultantes tienen caracteristicas de flujo, supresion de polvo, propiedades organolepticas y estabilidad excelentes. Son muy adecuadas para administracion directo en la boca de un paciente, e ingestion para aliviar condiciones esofagicas y gastricas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0515492.7A GB0515492D0 (en) | 2005-07-28 | 2005-07-28 | Improvements in or relating to compositions,articles and methods |
PCT/GB2006/002807 WO2007113454A1 (en) | 2005-07-28 | 2006-07-27 | Particulate compositions comprising alginate and/or alginic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008001317A true MX2008001317A (es) | 2008-03-18 |
Family
ID=34976748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008001317A MX2008001317A (es) | 2005-07-28 | 2006-07-27 | Composiciones en forma de particulas que comprenden alginato y/o acido alginico. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080317855A1 (es) |
EP (1) | EP1919487B1 (es) |
JP (1) | JP2009502897A (es) |
KR (1) | KR101362344B1 (es) |
CN (2) | CN101227914A (es) |
CA (1) | CA2616543A1 (es) |
ES (1) | ES2388699T3 (es) |
GB (1) | GB0515492D0 (es) |
MX (1) | MX2008001317A (es) |
MY (1) | MY147485A (es) |
PL (1) | PL1919487T3 (es) |
RU (1) | RU2441648C2 (es) |
TW (1) | TW200730182A (es) |
WO (1) | WO2007113454A1 (es) |
ZA (1) | ZA200711022B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10092524B2 (en) * | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
BRPI0917191A2 (pt) * | 2008-08-22 | 2015-11-10 | Reckitt Benckiser Healthcare | aperfeiçoamentos em ou relacionados a composições |
WO2012095567A1 (fr) * | 2011-01-12 | 2012-07-19 | Setalg | Composition pulverulente d'alginate, kit de preparation, et utilisations |
KR20120108218A (ko) * | 2011-03-23 | 2012-10-05 | 동아제약주식회사 | 위식도 역류질환 치료용 액상 타입 조성물 |
US20120283668A1 (en) * | 2011-05-04 | 2012-11-08 | Pinchas Shalev | Apparatus and method for using effervescent tablets for cosmetic care |
US9993497B2 (en) | 2012-12-30 | 2018-06-12 | Hadasit Medical Research Services And Development Ltd. | Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent |
GB201415381D0 (en) * | 2014-08-29 | 2014-10-15 | Algipharma As | Inhalable powder formulations of alginate oligomers |
CA3033065A1 (en) * | 2016-08-11 | 2018-02-15 | Adamis Pharmaceuticals Corporation | Drug compositions |
EP3655470B1 (en) * | 2017-07-20 | 2023-09-20 | Solvay SA | Functionalized particulate bicarbonate as blowing agent, foamable polymer composition containing it, and its use in manufacturing a thermoplastic foamed polymer |
WO2019113493A1 (en) | 2017-12-08 | 2019-06-13 | Adamis Pharmaceuticals Corporation | Drug compositions |
CA3092619A1 (en) * | 2018-03-02 | 2019-09-06 | Pharagen Llc | Formulations for treating acid reflux comprising sodium alginate |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT307616B (de) * | 1969-05-02 | 1973-05-25 | Biochemie Gmbh | Verfahren zur Herstellung einer Brausezubereitung |
GB1524740A (en) * | 1976-11-09 | 1978-09-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions for use in the suppression of gastric reflux |
GB1566609A (en) * | 1977-03-10 | 1980-05-08 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions containing cholestyramine and alginic acid |
GB9010039D0 (en) * | 1990-05-03 | 1990-06-27 | Reckitt & Colmann Prod Ltd | Medicament preparation |
GB9224855D0 (en) * | 1992-11-27 | 1993-01-13 | Smithkline Beecham Plc | Pharmaceutical compositions |
US6004581A (en) * | 1995-12-21 | 1999-12-21 | Farmaceutisk Laboratorium Ferring A/S | Modified release oral pharmaceutical composition and method for the treatment of bowel diseases |
US6071539A (en) * | 1996-09-20 | 2000-06-06 | Ethypharm, Sa | Effervescent granules and methods for their preparation |
IN186245B (es) * | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
JPH11124326A (ja) * | 1997-10-17 | 1999-05-11 | Earth Chem Corp Ltd | 色素の飛散防止方法 |
EE200100153A (et) * | 1998-09-14 | 2002-06-17 | Ranbaxy Laboratories Limited | Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli |
DE19859231A1 (de) * | 1998-12-21 | 2000-06-29 | Kurt Heinz Bauer | Schäumende Antacida-Suspensionstabletten |
US6258381B1 (en) * | 2000-02-11 | 2001-07-10 | Mcneil-Ppc, Inc. | Tablet and process for making the same |
GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
JP2004121061A (ja) * | 2002-10-01 | 2004-04-22 | Sanei Gen Ffi Inc | 粉末組成物の製造方法 |
EP1417958A1 (en) * | 2002-11-08 | 2004-05-12 | Pari GmbH | Wet granulation process |
EP1698349A4 (en) * | 2003-12-25 | 2009-12-16 | Takeda Pharmaceutical | PROCESS FOR IMPROVING THE SUITABILITY FOR GRANULATION |
EP1642887A1 (de) * | 2004-09-18 | 2006-04-05 | Cognis IP Management GmbH | Quaternisierte Fettsäureamidoamine |
-
2005
- 2005-07-28 GB GBGB0515492.7A patent/GB0515492D0/en not_active Ceased
-
2006
- 2006-07-26 TW TW095127278A patent/TW200730182A/zh unknown
- 2006-07-26 MY MYPI20063578A patent/MY147485A/en unknown
- 2006-07-27 PL PL06849422T patent/PL1919487T3/pl unknown
- 2006-07-27 RU RU2008107596/15A patent/RU2441648C2/ru active
- 2006-07-27 ES ES06849422T patent/ES2388699T3/es active Active
- 2006-07-27 KR KR1020087002524A patent/KR101362344B1/ko active IP Right Grant
- 2006-07-27 US US11/994,359 patent/US20080317855A1/en not_active Abandoned
- 2006-07-27 CN CNA2006800270095A patent/CN101227914A/zh active Pending
- 2006-07-27 CA CA002616543A patent/CA2616543A1/en not_active Abandoned
- 2006-07-27 WO PCT/GB2006/002807 patent/WO2007113454A1/en active Application Filing
- 2006-07-27 MX MX2008001317A patent/MX2008001317A/es active IP Right Grant
- 2006-07-27 CN CN201510391224.4A patent/CN104922148A/zh active Pending
- 2006-07-27 JP JP2008523454A patent/JP2009502897A/ja active Pending
- 2006-07-27 EP EP06849422A patent/EP1919487B1/en active Active
-
2007
- 2007-12-19 ZA ZA200711022A patent/ZA200711022B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PL1919487T3 (pl) | 2012-11-30 |
AU2006341307A1 (en) | 2007-10-11 |
MY147485A (en) | 2012-12-14 |
TW200730182A (en) | 2007-08-16 |
GB0515492D0 (en) | 2005-08-31 |
RU2008107596A (ru) | 2009-09-10 |
EP1919487B1 (en) | 2012-06-27 |
CA2616543A1 (en) | 2007-10-11 |
ZA200711022B (en) | 2009-07-29 |
JP2009502897A (ja) | 2009-01-29 |
RU2441648C2 (ru) | 2012-02-10 |
KR101362344B1 (ko) | 2014-02-12 |
CN101227914A (zh) | 2008-07-23 |
ES2388699T3 (es) | 2012-10-17 |
KR20080030643A (ko) | 2008-04-04 |
CN104922148A (zh) | 2015-09-23 |
EP1919487A1 (en) | 2008-05-14 |
WO2007113454A1 (en) | 2007-10-11 |
US20080317855A1 (en) | 2008-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008001317A (es) | Composiciones en forma de particulas que comprenden alginato y/o acido alginico. | |
WO2008120207A3 (en) | Compositions for nasal delivery | |
EP4219566A3 (en) | Recombinant rsv antigens | |
WO2011056748A3 (en) | Oral compositions for treatment of dry mouth | |
WO2007016093A3 (en) | Peroxide removal from drug delivery vehicle | |
IL178722A0 (en) | Compressed pharmaceutical compositions comprising peg and electrolytes | |
WO2007041156A3 (en) | Antibiotic formulations, unit doses, kits, and methods | |
WO2007008537A3 (en) | Nanoparticulate clarithromycin formulations | |
EP3492069A3 (en) | Pharmaceutical compositions | |
WO2007135241A3 (en) | Composition and method for binding acetaldehyde in stomach | |
MX2008001706A (es) | Conjugados de una porcion g-csf y un polimero. | |
MX2007004047A (es) | Goma de caramelo que comprende chocolate. | |
NZ600933A (en) | Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid | |
WO2009048251A3 (en) | Pharmaceutical composition containing micronized particles of naphthoquinone-based compound | |
WO2010020772A3 (en) | Sore throat compositions | |
WO2006097558A3 (es) | Nanopartículas de quitosano y polientilenglicol como sistema de administración de moléculas biológicamente activas | |
WO2008049042A3 (en) | Ophthalmic compositions containing diglycine | |
WO2007150075A3 (en) | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | |
EP1561760A3 (en) | Low molecular weight heparin salt with thriethanolamine | |
EP2537857A3 (en) | Mutant forms of streptolysin O | |
EP2277540A3 (en) | Polyanionic polymer adjuvants for haemophilus influenza B saccharide vaccines | |
WO2007044611A3 (en) | Methods for weight management | |
JP2010538176A5 (es) | ||
MX2009003169A (es) | Derivados de sulfonamida. | |
WO2009031594A1 (ja) | ジチオカルバメート基を有する高分子化合物からなる金属微粒子分散剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |